MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
22.74
+1.09 (5.03%)
At close: Dec 11, 2024, 4:00 PM
22.70
-0.04 (-0.18%)
After-hours: Dec 11, 2024, 5:11 PM EST
MBX Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 132.87 | 30.52 | 24.21 |
Short-Term Investments | 144.2 | 50.15 | 18.25 |
Cash & Short-Term Investments | 277.06 | 80.68 | 42.46 |
Cash Growth | 552.51% | 90.00% | - |
Other Receivables | 0.86 | 0.21 | 0.14 |
Receivables | 0.86 | 0.21 | 0.14 |
Prepaid Expenses | 2.41 | 2.45 | 1.52 |
Other Current Assets | 0.84 | 0.13 | 0.08 |
Total Current Assets | 281.17 | 83.47 | 44.21 |
Property, Plant & Equipment | 1.18 | 0.67 | 0.84 |
Other Long-Term Assets | 0.05 | 0.05 | 0.04 |
Accounts Payable | 5 | 1.39 | 0.98 |
Accrued Expenses | 5.75 | 2.38 | 2.32 |
Current Portion of Leases | 0.17 | 0.15 | 0.14 |
Total Current Liabilities | 10.92 | 3.93 | 3.43 |
Long-Term Leases | 0.04 | 0.17 | 0.32 |
Other Long-Term Liabilities | 0.07 | 0.19 | 0.07 |
Common Stock | 0.01 | 0 | 0 |
Additional Paid-In Capital | 393.18 | 3.05 | 0.41 |
Retained Earnings | -121.92 | -75.58 | -43.02 |
Comprehensive Income & Other | 0.11 | 0.06 | 0 |
Total Common Equity | 271.37 | -72.47 | -42.61 |
Total Liabilities & Equity | 282.4 | 84.18 | 45.1 |
Total Debt | 0.21 | 0.32 | 0.46 |
Net Cash (Debt) | 276.85 | 80.35 | 42 |
Net Cash Growth | 559.17% | 91.31% | - |
Net Cash Per Share | 20.11 | 6.56 | 5.24 |
Filing Date Shares Outstanding | 33.42 | 15.11 | 8.02 |
Total Common Shares Outstanding | 33.38 | 15.11 | 8.02 |
Working Capital | 270.25 | 79.54 | 40.78 |
Book Value Per Share | 8.13 | -4.80 | -5.31 |
Tangible Book Value | 271.37 | -72.47 | -42.61 |
Tangible Book Value Per Share | 8.13 | -4.80 | -5.31 |
Machinery | 1 | 0.24 | 0.23 |
Construction In Progress | 0 | 0 | - |
Leasehold Improvements | 0.39 | 0.37 | 0.35 |
Source: S&P Capital IQ. Standard template.
Financial Sources.